Page last updated: 2024-08-24

triazoles and Cancer of Nose

triazoles has been researched along with Cancer of Nose in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chng, WJ; Choo, SN; Chung, TH; Fan, S; Ham, MF; Ito, Y; Nah, GSS; Ng, SB; Osato, M; Salto-Tellez, M; Selvarajan, V; Shimizu, N; Voon, DC; Yan, J	1

Other Studies

1 other study(ies) available for triazoles and Cancer of Nose

Article	Year
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC. Leukemia, 2017, Volume: 31, Issue:10 Topics: Apoptosis; Azepines; Binding Sites; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; Core Binding Factor Alpha 3 Subunit; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Vectors; Humans; Lymphoma, Extranodal NK-T-Cell; Molecular Targeted Therapy; Nose Neoplasms; Protein Interaction Mapping; Proto-Oncogene Proteins c-myc; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Transcription, Genetic; Triazoles; Up-Regulation	2017

Article

Year

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.

Leukemia, 2017, Volume: 31, Issue:10

Topics: Apoptosis; Azepines; Binding Sites; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; Core Binding Factor Alpha 3 Subunit; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Vectors; Humans; Lymphoma, Extranodal NK-T-Cell; Molecular Targeted Therapy; Nose Neoplasms; Protein Interaction Mapping; Proto-Oncogene Proteins c-myc; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Transcription, Genetic; Triazoles; Up-Regulation

2017